DexCom's stock could drop even more if results falls short of revenue expectations. Whatever happens on Oct. 30, the medical ...

NEW YORK, Oct. 31, 2025 /PRNewswire/ — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law ...

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired DexCom, Inc. ("DexCom" or the "Company") (NASDAQ:DXCM) securities during ...

Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action lawsuit on behalf of purchasers and acquirers of DexCom, Inc. (NASDAQ: DXCM) securities between ...

The use of CGM has been growing among people without diabetes, including those with prediabetes, particularly with the ...

Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the ...

The global digital health market is set to witness a significant growth rate of 20-25% in the next 5 years. increasing adoption of smartphones and wearable devices, rising demand for remote healthcare ...

Insulet (($PODD)) announced an update on their ongoing clinical study. Insulet Corporation is currently conducting a study titled ‘Feasibility of ...

Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of ...

After dealing with a deployment problem with glucose monitors earlier this year, interim CEO Jake Leach said improving ...

Thank you, operator, and welcome to DexCom's Third Quarter 2025 Earnings Call. Our agenda begins with Jake Leach, DexCom's President and Interim CEO, who will summarize our recent highlights and ...

Medical device maker Dexcom topped Wall Street estimates for third-quarter results on Thursday, driven by robust demand for its continuous glucose monitoring systems.